The mutations involving the GTP-ase RAS protein family and its downstream BRAF lead to loss of cell cycle regulation at key checkpoints, which are the main driver mutations for several tumor types, e.g., colorectal carcinogenesis [8]. The gene discussed is BRAF; the disease is neoplasm.